Form D · Other Technology
OnPoint Medical Diagnostics, Inc.
Rochester, MN · CIK 0001506366
Offering snapshot reported Dec 7, 2010 · SEC filing
- Reported sold
- $750K Offering amount: $1.5M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 18, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 7, 2010 | Initial | $750,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $150K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-151467
The stated sales commission is based on the total offering amount. The Selling Agent will also receive a non-accountable expense allowance of 3% of the principal amount sold and a warrant to purchase shares of the issuer's Common Stock.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Emergent Financial Group, Inc. | 37891 |
Source: Form D, filed Dec 7, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Cavanaugh | Executive |
| Gus Chafoulias | Director |
| George Danko | Director |
| Blake Whitney | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
221 First Avenue Sw, Suite 300
Rochester, MN, 55902
Rochester, MN, 55902